(FMCG News) On July 15, Chongqing Yichong Technology Co., Ltd. (referred to as: Yichong Technology) announced the completion of hundreds of millions of yuan in strategic financing. The investor is Tianjin Ruipu Biotechnology Co., Ltd., a leader in the animal health industry. Company (Abbreviation: Ruipu Biotechnology) (300119.SZ). This financing will be mainly used for the creation of Yichong Technology’s self-developed brand, the upgrading of the supply chain, the offline expansion of front-end business and the construction of pet medical digital information.

《FMCG "We learned that Yichong Technology was founded in 2008. It is a group company that provides omni-channel management services for pet brands and a composite supply chain empowerment group. Its chairman and manager is Xiao Yu. After more than 10 years of development, Yichong now owns the industry-renowned pet consumption and selection platform - E-Pet Mall, the pet store empowerment platform - Taipin, as well as popular self-catering brands represented by Little Blue Shark, Qiao Tail, and Zero Gray. Research the brand matrix. At the same time, Yichong Technology also owns an online operation and management platform for domestic and overseas brands - Hangzhou Yichong. It has established cooperative relationships with more than 1,300 pet brands and more than 30,000 pet stores at home and abroad, and has served more than 4 million pet-raising families. , forming a multi-business and multi-channel pet industry empowerment enterprise integrating high-quality R&D teams, operation management teams, integrated marketing teams, supply chain empowerment teams, etc.

Rip Biotech was founded in 1998. It is a leading animal health enterprise integrating the research and development, production and sales of animal vaccines, pharmaceutical preparations, APIs and functional additives. It has 14 subsidiaries. , whose chairman and general manager are Li Shoujun.

With the help of this investment , Yichong Technology will closely grasp its economic development trends, focus on branding, digitalization, and intelligence, extend pet life cycle health management services, give full play to the platform value of omni-channel brand services, and promote the implementation of the Internet + pet medical market layout .

Rip Biotechnology will also leverage its advantages in the full range of animal health care product matrix and biological products technology to provide R&D support for Yichong Technology and promote the construction of an integrated ecological platform for production, research and application of Yichong Technology in the pet industry. .